Results in immunology最新文献

{"title":"Ly6G-mediated depletion of neutrophils is dependent on macrophages","authors":"Kevin W. Bruhn ,&nbsp;Ken Dekitani ,&nbsp;Travis B. Nielsen ,&nbsp;Paul Pantapalangkoor ,&nbsp;Brad Spellberg","doi":"10.1016/j.rinim.2015.12.001","DOIUrl":"https://doi.org/10.1016/j.rinim.2015.12.001","url":null,"abstract":"<div><p>Antibody-mediated depletion of neutrophils is commonly used to study neutropenia. However, the mechanisms by which antibodies deplete neutrophils have not been well defined. We noticed that mice deficient in complement and macrophages had blunted neutrophil depletion in response to anti-Ly6G monoclonal antibody (MAb) treatment. <em>In vitro</em>, exposure of murine neutrophils to anti-Ly6G MAb in the presence of plasma did not result in significant depletion of cells, either in the presence or absence of complement. <em>In vivo</em>, anti-Ly6G-mediated neutrophil depletion was abrogated following macrophage depletion, but not complement depletion, indicating a requirement for macrophages to induce neutropenia by this method. These results inform the use and limitations of anti-Ly6G antibody as an experimental tool for depleting neutrophils in various immunological settings.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 5-7"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2015.12.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136551534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advisory board","authors":"","doi":"10.1016/S2211-2839(16)30005-3","DOIUrl":"https://doi.org/10.1016/S2211-2839(16)30005-3","url":null,"abstract":"","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages i-ii"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2211-2839(16)30005-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136551533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Constitutive expression of genes encoding notch receptors and ligands in developing lymphocytes, nTreg cells and dendritic cells in the human thymus","authors":"Luciana Bento-de-Souza ,&nbsp;Jefferson R. Victor ,&nbsp;Luiz C. Bento-de-Souza ,&nbsp;Magaly Arrais-Santos ,&nbsp;Andréia C. Rangel-Santos ,&nbsp;Érica Pereira-Costa ,&nbsp;Elaine Raniero-Fernandes ,&nbsp;Maria I. Seixas-Duarte ,&nbsp;João B. Oliveira-Filho ,&nbsp;Alberto J. Silva Duarte","doi":"10.1016/j.rinim.2016.04.001","DOIUrl":"10.1016/j.rinim.2016.04.001","url":null,"abstract":"<div><p>The thymus is the site of T cell maturation. Notch receptors (Notch1-4) and ligands (DLL1-3 and Jagged1-2) constitute one of several pathways involved in this process. Our data revealed differential constitutive expression of Notch genes and ligands in T lymphocytes and thymic dendritic cells (tDCs), suggesting their participation in human thymocyte maturation. nTreg analyses indicated that the Notch components function in parallel to promote maturation in the thymus.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 15-20"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2016.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34740730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ascorbic acid serum levels are reduced in patients with hematological malignancies","authors":"Mirelle J.A.J. Huijskens ,&nbsp;Will K.W.H. Wodzig ,&nbsp;Mateusz Walczak ,&nbsp;Wilfred T.V. Germeraad ,&nbsp;Gerard M.J. Bos","doi":"10.1016/j.rinim.2016.01.001","DOIUrl":"https://doi.org/10.1016/j.rinim.2016.01.001","url":null,"abstract":"<div><p>In this paper we demonstrate that patients treated with chemotherapy and/or hematopoietic stem cell transplantation (HSCT) have highly significant reduced serum ascorbic acid (AA) levels compared to healthy controls. We recently observed in <em>in vitro</em> experiments that growth of both T and NK cells from hematopoietic stem cells is positively influenced by AA. It might be of clinical relevance to study the function and recovery of immune cells after intensive treatment, its correlation to AA serum levels and the possible effect of AA supplementation.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 8-10"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2016.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136551393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immunomodulation for treatment of drug and device refractory gastroparesis","authors":"Kaartik Soota ,&nbsp;Archana Kedar ,&nbsp;Yana Nikitina ,&nbsp;Evelyn Arendale ,&nbsp;Vetta Vedanarayanan ,&nbsp;Thomas L. Abell","doi":"10.1016/j.rinim.2016.02.001","DOIUrl":"https://doi.org/10.1016/j.rinim.2016.02.001","url":null,"abstract":"<div><h3>Objective</h3><p>Patients with generalized autoimmune dysautonomia may also present with gastroparesis. Immune dysfunction in such patients can be evaluated using antibodies to glutamic acid decarboxylase (GAD) and full thickness biopsy of stomach. In this study, we utilize immunotherapy for treatment of drug and Gastric Electrical Stimulation (GES) resistant gastroparetic patients with evidence of neuroinflammation on full thickness gastric biopsy and had positive GAD65 autoantibodies.</p></div><div><h3>Material and methods</h3><p>We conducted a retrospective chart review of 11 female patients with drug and device resistant gastroparesis. Patients were treated for a total of 8–12 weeks with either intravenous immunoglobulin (IVIg), or combined mycophenolate mofetil (MM) and methylprednisolone, or only MM. Patients were excluded if they had previous side effects from steroid therapy, low scores on dual-energy X-ray absorptiometry (DEXA) scan results, immune-compromised conditions with infections like tuberculosis and zoster. Symptoms of nausea, vomiting, abdominal pain, early satiety/anorexia, bloating and total symptom score (TSS) as reported by the patients were recorded before and after the treatment at a follow up visit 2 to 16 weeks after initiation of therapy.</p></div><div><h3>Results</h3><p>Maximum symptom improvement was seen in patients treated with IVIg (67%). 6 patients (55%) had improvement in vomiting, whereas 5 patients (45%) had improvements in nausea, abdominal pain and bloating.</p></div><div><h3>Conclusions</h3><p>Immunomodulatory therapy shows positive outcomes in improving vomiting symptom in some gastroparetic patients who have coexisting positive autoimmune profiles. This preliminary data suggests the need for further investigations in immunotherapy targeted to patients with gastroparetic symptoms refractory to approved drug and device therapies.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 11-14"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2016.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136551532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"De novo assembly of the blunt snout bream (Megalobrama amblycephala) gill transcriptome to identify ammonia exposure associated microRNAs and their targets","authors":"Shengming Sun ,&nbsp;Xianping Ge ,&nbsp;Jian Zhu ,&nbsp;Wuxiao Zhang ,&nbsp;Fujun Xuan","doi":"10.1016/j.rinim.2016.03.001","DOIUrl":"10.1016/j.rinim.2016.03.001","url":null,"abstract":"<div><p>De novo transcriptome sequencing is a robust method for microRNA (miRNA) target gene prediction, especially for organisms without reference genomes. Following exposure of <em>Megalobrama amblycephala</em> to ammonia (0.1 or 20<!--> <!-->mg<!--> <!-->L⁻¹ ), two cDNA libraries were constructed from the fish gills and sequenced using Illumina HiSeq 2000. Over 90 million reads were generated and de novo assembled into 46, 615 unigenes, which were then extensively annotated by comparing to different protein databases, followed by biochemical pathway prediction. The expression of 2666 unigenes significantly differed; 1961 were up-regulated, while 975 were down-regulated. Among these, 250 unigenes were identified as the targets for 10 conserved and 4 putative novel miRNA families by miRNA target computational prediction. We examined expression of ssa-miRNA-21 and its target genes by real-time quantitative PCR and found agreement with the sequencing data. This study demonstrates the feasibility of identifying miRNA targets by transcriptome analysis. The transcriptome assembly data represent a substantial increase in the genomic resources available for <em>Megalobrama amblycephala</em> and will be useful for gene expression profile analysis and miRNA functional annotation.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 21-27"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2016.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34740731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"N-terminal amphipathic helix of Amphiphysin can change the spatial distribution of immunoglobulin E receptors (FcεRI) in the RBL-2H3 mast cell synapse","authors":"Kathrin Spendier","doi":"10.1016/j.rinim.2015.11.001","DOIUrl":"10.1016/j.rinim.2015.11.001","url":null,"abstract":"<div><p>Biomembranes undergo extensive shape changes as they perform vital cellular functions or become diseased. To understand the mechanisms by which lipids and proteins control membrane curvature during various processes, researchers have identified and engineered many curvature-inducing and curvature-sensing proteins and peptides. In this paper, a simple experiment was performed to show qualitatively how membrane remodeling by N-terminal amphipathic helix of Amphiphysin affects the spatial distribution of the transmembrane Fc receptor protein (FcεRI) in mast cells. Results indicate that an elevated concentration of amphipathic helices can interfere with the formation of a typical mast cell synapse.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"6 ","pages":"Pages 1-4"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2015.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"105896364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D","authors":"Michael J. Korrer ,&nbsp;John M. Routes","doi":"10.1016/j.rinim.2015.01.001","DOIUrl":"10.1016/j.rinim.2015.01.001","url":null,"abstract":"<div><p>The expression of the Adenovirus serotype 2 or serotype 5 (Ad2/5) E1A gene in tumor cells upregulates ligands that are recognized by the NKG2D activating receptor, which is expressed on NK cells and T cells, and reduces their tumorigenicity, a process dependent on NK cells and T cells. In some model systems, the forced overexpression of NKG2D ligands on tumor cells induced antigen-specific CD8+ T cells that mediated anti-tumor immunity. We wanted to determine if the interaction of NKG2D ligands on tumor cells that express E1A with NKG2D on immune cells contributed to the ability of E1A to induce a CD8+ T cell anti-tumor response or reduce tumorigenicity. To address these questions, we used the MCA-205 tumor cell line or MCA-205 cells that expressed Ad5 E1A (MCA-205-E1A cells), a fusion protein of E1A and ovalbumin (MCA-205-E1A-OVA) or OVA (MCA-205-OVA). We found that the expression of E1A or E1A–OVA, but not OVA, upregulated the expression of the NKG2D ligand RAE-1 on the surface of MCA-205 cells. Additionally, MCA-205-E1A cells and MCA-205-E1A-OVA cells were more sensitive to NK cell lysis than MCA-205 or MCA-205-OVA cells in WT B6 mice, but not NKG2D deficient B6 mice. Next, we adoptively transferred WT or NKG2D deficient OT-1 T cells (CD8 T cells that recognize OVA residues 257–264) into WT B6 mice or B6 mice that were deficient in NKG2D respectively and measured the expansion of OT-1 cells following immunization with MCA-205-E1A-OVA or MCA-205-OVA cells. We found that the expansion of OT-1 cells following immunization of either OVA-expressing MCA-205 cell lines was not affected by the presence or absence of NKG2D in B6 mice. Finally, we found that the capacity of E1A to reduce the tumorigenicity of MCA-205 cells was not impaired in B6-NKG2D deficient mice as compared to WT B6 mice. Our results suggest that the ability of E1A to reduce the tumorigenicity of MCA-205 cells, or induce an antigen-specific CD8+ T cell response, is independent of the interaction of NKG2D ligands with the NKG2D receptor.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"5 ","pages":"Pages 1-5"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2015.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33058116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis","authors":"Giuseppe A. Ramirez ,&nbsp;Miriam Blasi ,&nbsp;Clara Sciorati ,&nbsp;Patrizia Rovere-Querini ,&nbsp;Angelo A. Manfredi","doi":"10.1016/j.rinim.2015.10.002","DOIUrl":"https://doi.org/10.1016/j.rinim.2015.10.002","url":null,"abstract":"<div><p>Anti-Neutrophil Cytoplasmic Antibodies (ANCA)-associated vasculitides (AAV) are characterized by small vessel injury and in some cases granulomatous lesions and glomerular inflammation. The pathogenic bases of these clinical phenotypes are incompletely understood, but evidence from patients with AAV and other inflammatory diseases suggest a role for monocyte/macrophages in the perpetuation of tissue injury. Macrophage colony stimulating factor (M-CSF) is a promoter of monocyte recruitment and macrophage proliferation, involved in mesangial cell proliferation and experimental nephritis development. Serum concentrations of M-CSF mark and herald the onset of lupus nephritis. Plasma samples from 29 patients with AAV (18 granulomatosis with polyangiitis, GPA, 6 eosinophilic granulomatosis with polyangiitis, EGPA, and 5 microscopic polyangiitis, MPA) and from 10 healthy controls were collected together with clinical data. Patients with AAV had higher levels of M-CSF when compared to controls. M-CSF levels correlated positively with the BVAS, serum C-reactive protein and erythrocyte sedimentation rate, while haemoglobin correlated inversely with M-CSF. Patients with active renal disease had significantly higher levels of M-CSF when compared to the other subgroups. M-CSF levels did not differ between ANCA subserotypes and were not associated with the involvement of other organs. In conclusion, M-CSF is higher in patients with AAV and active nephritis and could contribute to the pathogenesis of these diseases. In addition, M-CSF could behave as a useful marker of renal involvement in AAV.</p></div>","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"5 ","pages":"Pages 33-36"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rinim.2015.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137283407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advisory Board","authors":"","doi":"10.1016/S2211-2839(15)00003-9","DOIUrl":"https://doi.org/10.1016/S2211-2839(15)00003-9","url":null,"abstract":"","PeriodicalId":89845,"journal":{"name":"Results in immunology","volume":"5 ","pages":"Pages i-ii"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2211-2839(15)00003-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137283447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}